过度表达CBLN2可以抑制结直肠癌的进展,并改善免疫治疗反应
Zeyu Wang1, Hongjing Pan2, Jun Zhou2
1Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
International immunopharmacology
|November 22, 2024
概括
大脑蛋白2 (CBLN2) 在结直肠癌中被降低,阻碍了抗瘤免疫力. 恢复CBLN2可能会改善患者的治疗结果,并提高免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 大脑蛋白2 (CBLN2) 对于神经元功能至关重要,但其在癌症中的作用尚不清楚.
- 大肠直肠癌 (CRC) 是一个重要的全球健康问题,需要新的治疗点.
研究的目的:
- 研究CBLN2在结直肠癌 (CRC) 中的作用.
- 探索CBLN2作为CRC治疗点的潜力.
主要方法:
- 在CRC患者样本中分析CBLN2表达.
- 研究CBLN2与免疫透物之间的关联.
- 对CBLN2-STAT3通路的机制研究.
- 在体外和体内实验评估CBLN2过度表达效应的实验.
- 评估CBLN2对免疫检查点阻塞 (ICB) 治疗疗效的影响.
主要成果:
- 在CRC中CBLN2表达显著下调,与患者预后不佳相关.
- CBLN2水平与免疫细胞透有关,特别是CD8+ T细胞.
- CBLN2 抑制了通过 STAT3 介导的 PD-L1 和β-catenin 的激活.
- 过度表达CBLN2抑制了CRC细胞的瘤性和瘤生长.
- 在临床前CRC模型中,CBLN2激活增强了ICB治疗的疗效.
结论:
- CBLN2-STAT3轴代表了结直肠癌的新型治疗标.
- 恢复CBLN2功能可能会克服CRC中免疫治疗的耐药性.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K